信息
GEXVal CEO Speaks at University of Tokyo Hospital Drug Discovery Training Program
2025年11月21日
株式會社GEXValNovember 21, 2025 GEXVal CEO Delivers a Lecture at University of Tokyo Hospital TR/Academia Drug Dis […]
GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome
2025年11月19日
株式會社GEXValNovember 19, 2025 GEXVal Receives FDA Orphan Drug Designation for GXV-001 in Fragile X Syndrome GEXV […]
GEXVal CEO to Speak at China Healthcare Summit 2025
2025年10月20日
株式會社GEXValOctober 20, 2025 GEXVal CEO Invited and to Speak at BioCentury-BayHelix China Healthcare Summit 20 […]
GEXVal CTO to Present at CBI Annual Meeting 2025
2025年10月17日
株式會社GEXValOctober 17, 2025 GEXVal CTO to Present at Chemo-Bio Informatics Society (CBI) Annual Meeting 2025 […]